You are viewing the site in preview mode

Skip to main content

Table 1 (abstract A5). Immunomodulatory Medication Use in Youth with Newly-Diagnosed SLE, N=650

From: Proceedings of the 2019 Childhood Arthritis and Rheumatology Research Alliance (CARRA) Annual Scientific Meeting

Proportion with prescription fills after first SLE diagnosis code, n (%) Within 3 months Within 6 months Within 1 year
Immunomodulatory medication (hydroxychloroquine or immunosuppressant) 428 (66) 460 (71) 511 (78)
Hydroxychloroquine 374 (58) 407 (63) 457 (70)
Immunosuppressant 114 (18) 162 (25) 221 (34)
  1. Immunosuppressant medications include: mycophenolate mofetil, azathioprine, leflunomide, methotrexate, tacrolimus, and oral cyclophosphamide
Back to article page

Pediatric Rheumatology

ISSN: 1546-0096